Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Mar 7 | ANIP | Ani Pharmaceuticals INC | FTAX | 3,314 | $74.04 | $245.4K | -3.9% | Open the original filing on SEC.gov |
| Mar 3 | ANIP | Ani Pharmaceuticals INC | SSELL | 2,060 | $76.50 | $157.6K | -2.4% | Open the original filing on SEC.gov |
| Feb 28 | ANIP | Ani Pharmaceuticals INC | FTAX | 2,221 | $73.90 | $164.1K | -2.5% | Open the original filing on SEC.gov |
| Feb 26 | ANIP | Ani Pharmaceuticals INC | AGRANT | 12,969 | $77.15 | $1M | +17.0% | Open the original filing on SEC.gov |
| Feb 14 | ANIP | Ani Pharmaceuticals INC | FTAX | 1,888 | $77.36 | $146.1K | -2.4% | Open the original filing on SEC.gov |
| Feb 12 | ANIP | Ani Pharmaceuticals INC | FTAX | 1,775 | $76.70 | $136.1K | -2.2% | Open the original filing on SEC.gov |
| Feb 11 | ANIP | Ani Pharmaceuticals INC | FTAX | 4,267 | $76.25 | $325.4K | -5.1% | Open the original filing on SEC.gov |
| Aug 12, 2025 | ANIP | Ani Pharmaceuticals INC | SSELL | 5,873 | $86.53 | $508.2K | -6.5% | Open the original filing on SEC.gov |
| May 15, 2025 | ANIP | Ani Pharmaceuticals INC | SSELL | 881 | $60.07 | $52.9K | -1.0% | Open the original filing on SEC.gov |